Skip to content

Clinical trials

Completed Observational Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Observational Status: Completed Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20041
20054
20062
20077
200810
20095
20108
20116
20128
20132
20149
20153
20169
20174
20184
20196
20204
20216
20223
20234
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed120

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca18
National Heart, Lung, and Blood Institute (NHLBI)4
Hanmi Pharmaceutical Company Limited3
Organon and Co3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Abbott2
Canadian Heart Research Centre2
Daewoong Pharmaceutical Co. LTD.2
Daiichi Sankyo2
Elpen Pharmaceutical Co. Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias120
Hypertension23
Diabetes Mellitus18
Diabetes Mellitus, Type 217
Cardiovascular Diseases14
Hypercholesterolemia14
Obesity14
Insulin Resistance7
Atherosclerosis6
Hyperlipidemias6

Trials

Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.